Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novo Nordisk A/S (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
NVO
New York
2834
https://www.novonordisk.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novo Nordisk A/S (ADR)
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says
- Mar 29th, 2024 6:00 am
2 Top Biotech Buyout Candidates
- Mar 28th, 2024 5:55 pm
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
- Mar 28th, 2024 1:50 pm
Insiders Are Dumping These 10 Healthcare Stocks
- Mar 28th, 2024 12:13 pm
Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
- Mar 27th, 2024 4:42 pm
Viking Therapeutics stock rises on positive Phase 1 weight-loss pill data
- Mar 26th, 2024 4:59 pm
Viking Therapeutics Posts Promising Early Weight-Loss Data as Cost Worries Escalate
- Mar 26th, 2024 3:13 pm
Novo Nordisk (NVO) to Buy Cardior to Boost Heart Disease Pipeline
- Mar 26th, 2024 2:56 pm
Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy?
- Mar 26th, 2024 2:35 pm
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
- Mar 26th, 2024 9:51 am
32 Countries with the Highest Rates of Diabetes
- Mar 26th, 2024 9:10 am
Why the Market Dipped But Novo Nordisk (NVO) Gained Today
- Mar 25th, 2024 9:50 pm
Novo Nordisk strikes €1bn deal to expand into heart disease treatments
- Mar 25th, 2024 3:52 pm
Tesla, Lucid, Novo Nordisk: Trending tickers
- Mar 25th, 2024 2:43 pm
Novo Nordisk Buys Heart Disease Biotech for Up to $1.1 Billion
- Mar 25th, 2024 1:49 pm
Uncovering Hidden Gems: 1 AI-Powered Healthcare Stock Set to Dominate the Market
- Mar 25th, 2024 1:07 pm
UPDATE 2-Novo ready to seek German insurance coverage of Wegovy for heart use
- Mar 25th, 2024 12:54 pm
Novo Nordisk A/S - share repurchase programme
- Mar 25th, 2024 11:58 am
Novo to acquire heart failure drug in $1B deal for Cardior
- Mar 25th, 2024 11:13 am
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
- Mar 25th, 2024 10:25 am
Scroll